Dissemin is shutting down on January 1st, 2025

Published in

Society of Hospital Pharmacists of Australia, Journal of Pharmacy Practice and Research, 1(39), p. 55-58, 2009

DOI: 10.1002/j.2055-2335.2009.tb00705.x

Links

Tools

Export citation

Search in Google Scholar

Cytochrome P450 Part 3: Impact of Drug-Drug Interactions

Journal article published in 2009 by Michael B. Ward, Michael J. Sorich, Allan M. Evans, Ross A. McKinnon ORCID
This paper is available in a repository.
This paper is available in a repository.

Full text: Download

Question mark in circle
Preprint: policy unknown
Question mark in circle
Postprint: policy unknown
Question mark in circle
Published version: policy unknown
Data provided by SHERPA/RoMEO

Abstract

The role of individual hepatic cytochrome P450 (CYP) enzymes in drug metabolism and the factors that modulate CYP activity are becoming increasingly well understood. These advances have resulted in a better understanding of drug-drug and drug- food interactions and an enhanced capacity to predict drug interactions that may occur with new drugs. This final article in the series describes the issues and principles that are important in identifying and assessing drug interactions that involve CYP enzymes.